Heart Disease: 8 Factors That Raise Your Risk
Doctors are thinking differently about what drives cardiovascular issues. It’s no longer just about blood pressure and cholesterol.
Related Articles
Trump’s Strange Bedfellows: Arab Americans and Right-Leaning Jews
Donald J. Trump won votes from Arab Americans and pro-Israel American Jews. Someone is likely to be disappointed.
Study links high blood sugar to thrombosis risk in diabetes
A study conducted at the Center for Research on Redox Processes in Biomedicine (Redoxoma) helps understand how high blood sugar (hyperglycemia), one of the manifestations…
Violence in Amsterdam: Israeli soccer fans attacked by Arabs
Hundreds of Maccabi Tel Aviv fans report being attacked by Arabs as they left the stadium where Maccabi’s game against AFC Ajax took place. At…
Scientific Sessions Registration
Register for the AHA’s Scientific Sessions – the premier cardiovascular research event. Join leading experts in the field for engaging scientific discussions.
Dr. John Fruehauf on a New Standard of Care for Stage III Melanoma | Docwire News
Dr. John Fruehauf, Evolent, talks about a new standard of care in the treatment of stage III melanoma.
ECLIPSE on Orbital Atherectomy: Balloon Angioplasty Still Shines in Calcified Lesions | Docwire News
ECLIPSE investigated whether OA provides better outcomes than conventional balloon angioplasty in calcified coronary lesions.
U.S. Cohort Shows Stroke Reduction in PROTECTED TAVR Analysis | Docwire News
An analysis of PROTECTED TAVR trial highlighted potential regional differences in the efficacy of CEP during TAVR.
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Preclinical Cardiotoxicity Screening in Cardio-Oncology:
Highlights •hiPSC-CM offer an alternative to in vivo models for predicting cardiotoxicity.•hiPSC-CM monolayers detect pro-arrhythmic effects; inotropic detection is less established.•Cardiac sphero…
The Essential Role of Ongoing Reassessment of Patients With Secondary Tricuspid Regurgitation:
AbstractThis case report describes a patient diagnosed with severe secondary tricuspid regurgitation (TR) and pulmonary hypertension. Initial improvement with heart failure therapy was followed by…
Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia: The Phase 3 REMAIN-1 Randomized Trial
AbstractBackgroundMonoclonal antibodies against proprotein convertase subtilisin/kexin type 9 (PCSK9) have been used to reduce the level of low-density lipoprotein cholesterol (LDL-C), but require …